Why the study?
Doxorubicin causes destructive hepatic toxicity, requiring antioxidant coadministration to reduce its toxic effects, prompting investigation into the protective capacity of combined vitamin E and omega-3.
Does co-administration of Vitamin E and Omega-3 reduce doxorubicin-induced hepatotoxicity in mice?
Does co-administration of Vitamin E and Omega-3 reduce doxorubicin-induced hepatotoxicity in mice?
Co-administration of Vitamin E and Omega-3 may offer protective effects against doxorubicin-induced hepatotoxicity in a mouse model.
Answers are grounded in this paper and cite their sources.
May reduce doxorubicin hepatotoxicity in mice; leaves open translation to human oncology practice.
Background: Doxorubicin is a favorite drug for feasting many malignancies. All organs' hepatic toxic effects are destructive and lead to use with caution. Then, it is necessary to increase antioxidants accompanied with doxorubicin to reduce its toxicity. Vitamin E is an antioxidant with harmful consequences. Omega-3 is an antioxidant similarly. The healing capacity of Vitamin E- Omega-3 was investigated together against doxorubicin. Methods: Thirty balb/c mice have divided a weight of 25 g into five equal groups of six mice each. The groups were classified as Control: Normal saline; DOX: Doxorubicin; Vitamin E: Vitamin E + DOX; Omega-3; Omega-3 + DOX; Both Vitamin E- Omega-3 + DOX. The histopathology was set to describe vacuolar degeneration, inflammation, and necrosis. Immunohistochemistry was performed to estimate the expression of tumor necrosis factor (TNFα), demonstrating the inflammation. Results: DOX-induced hepatic injury and increased TNF-α expression were seen more than alone when co-administered with vitamin E and omega-3. A significant decrease was shown in the ALT, AST, GGT, and ALP levels compared to the control. The Glutathione peroxidase and Catalase enzyme activities were higher in the co-administered Vitamin E- Omega-3 group than that received Vit E or Omega-3. Conclusions: Co-administration of Vitamin E and Omega-3 have a more repair capacity with controlling effects on Doxorubicin-induced liver toxicity.
No takes yet. Share an insight, caveat, or question.
Lotfi et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: